nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A22. Anti-tumor effect of lipid A-derived NO
|
Bettaieb, A. |
|
2007 |
17 |
S |
p. 14- 1 p. |
artikel |
2 |
A26. A phase I/II pilot trial of low-dose, sustained-release GTN for prostate cancer patients with recurrence after primary therapy
|
Siemens, D.R. |
|
2007 |
17 |
S |
p. 15- 1 p. |
artikel |
3 |
A14. Arginase/NO balance in situ regulates T cell function in cancer patients
|
Ochoa, A.C. |
|
2007 |
17 |
S |
p. 12- 1 p. |
artikel |
4 |
A19. Chemo and immuno-sensitizing activities of nitric oxide (NO) and reversal of tumor resistance to apoptotic stimuli: Therapeutic implications
|
Bonavida, B. |
|
2007 |
17 |
S |
p. 13- 1 p. |
artikel |
5 |
A25. Clinical experience with the nitric oxide synthase inhibitor N-nitro-l-Arginine (LNNA) in malignant disease
|
Hoskin, P.J. |
|
2007 |
17 |
S |
p. 15- 1 p. |
artikel |
6 |
A18. Constitutive intracellular production of NO in human melanoma regulates resistance to apoptosis
|
Grimm, E. |
|
2007 |
17 |
S |
p. 13- 1 p. |
artikel |
7 |
A4. Cysteine thiyl radical: Common intermediate in RNS/ROS-induced signaling protein activation/inactivation
|
Lancaster, J.R. |
|
2007 |
17 |
S |
p. 9-10 2 p. |
artikel |
8 |
A1. Discrete concentrations of NO determine pro and antitumor responses
|
Wink, D. |
|
2007 |
17 |
S |
p. 9- 1 p. |
artikel |
9 |
A15. Heterogeneous nuclear ribonucleoprotein G (hnRNP G), DNA Repair and nitric oxide
|
Park, N.H. |
|
2007 |
17 |
S |
p. 12- 1 p. |
artikel |
10 |
A23. Impact of the modulation of endothelial-derived NO in tumors on anticancer therapies
|
Féron, O. |
|
2007 |
17 |
S |
p. 14- 1 p. |
artikel |
11 |
A5. Inducible nitric oxide synthase and intestinal tumorigenesis
|
Hull, M. |
|
2007 |
17 |
S |
p. 10- 1 p. |
artikel |
12 |
A20. Inductible nitric oxide synthase gene therapy for cancer
|
Hirst, D. |
|
2007 |
17 |
S |
p. 14- 1 p. |
artikel |
13 |
A12. Inflammation and cancer: Influence of nitric oxide
|
Hussain, S.P. |
|
2007 |
17 |
S |
p. 12- 1 p. |
artikel |
14 |
A10. Nitrates in chemoprevention: Correlating activity with structure and NO release
|
Thatcher, G. |
|
2007 |
17 |
S |
p. 11- 1 p. |
artikel |
15 |
A2. Nitric oxide and bioenergetics: Physiology and pathophysiology
|
Moncada, S. |
|
2007 |
17 |
S |
p. 9- 1 p. |
artikel |
16 |
A13. Nitric oxide and breast cancer: The two faces of NO
|
Chaudhuri, G. |
|
2007 |
17 |
S |
p. 12- 1 p. |
artikel |
17 |
A9. Nitric oxide mediates tumor vessel maturation
|
Fukumura, D. |
|
2007 |
17 |
S |
p. 11- 1 p. |
artikel |
18 |
A24. Nitroglycerin may increase response to anticancer drugs in non-small cell lung cancer via reduction of HIF-1α pathway
|
Yasuda, H. |
|
2007 |
17 |
S |
p. 15- 1 p. |
artikel |
19 |
A16. NO/cGMP regulation of cell death
|
Billiar, T.R. |
|
2007 |
17 |
S |
p. 13- 1 p. |
artikel |
20 |
A21. NO-donating anticancer compounds: An update
|
Rigas, B. |
|
2007 |
17 |
S |
p. 14- 1 p. |
artikel |
21 |
A17. Role of S-nitrosylation in apoptosis resistance and malignant transformation of human lung epithelial cells
|
Rojanasakul, Y. |
|
2007 |
17 |
S |
p. 13- 1 p. |
artikel |
22 |
A3. S-Nitrosylation of proteins updated
|
Stamler, J.S. |
|
2007 |
17 |
S |
p. 9- 1 p. |
artikel |
23 |
A8. Stimulation of the INOS pathway in chronic lymphocytic leukemia (CLL) cells by BAFF and TLR-7 ligation; involvement of the NF-kB pathway
|
Kolb, J.P. |
|
2007 |
17 |
S |
p. 11- 1 p. |
artikel |
24 |
A6. The role of nitrative DNA damage in inflammation-associated carcinogenesis
|
Ohshima, H. |
|
2007 |
17 |
S |
p. 10- 1 p. |
artikel |
25 |
A11. The versatile role of NO in tumor microenvironment
|
Brüne, B. |
|
2007 |
17 |
S |
p. 11-12 2 p. |
artikel |
26 |
A7. Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high glutathione content
|
Estrela, J.M. |
|
2007 |
17 |
S |
p. 10- 1 p. |
artikel |
27 |
Author Index
|
|
|
2007 |
17 |
S |
p. S30- 1 p. |
artikel |
28 |
B2. Activated CD8+ T cells radiosensitize EMT-6 mammary carcinoma cells through the interferon-gamma/iNOS pathway
|
De Ridder, M. |
|
2007 |
17 |
S |
p. 16- 1 p. |
artikel |
29 |
B3. A study to determine the role of iNOS as a radiosensitizer and potentiator of bioreductive drugs in human tumours
|
Fitzpatrick, B. |
|
2007 |
17 |
S |
p. 16- 1 p. |
artikel |
30 |
B11. Efficacy and mechanism of action of NCX 4040, a NO-donating acetyl salicylic acid derivative, as anticancer drug or sensitizing agent of conventional chemotherapeutic agents
|
Tesei, A. |
|
2007 |
17 |
S |
p. 18-19 2 p. |
artikel |
31 |
B5. iNOS expression is associated with basal-like breast cancer phenotype and predicts poor survival in ERneg breast cancer
|
Glynn, S. |
|
2007 |
17 |
S |
p. 17- 1 p. |
artikel |
32 |
B6. In silico screening and experimental validation of novel inhibitors of nitric oxide from a database of natural products derived from traditional chinese medicine
|
Konkimalla, V.B. |
|
2007 |
17 |
S |
p. 17- 1 p. |
artikel |
33 |
B1. Nitric oxide induces RKIP expression and sensitizes tumor cells to TRAIL-mediated apoptosis via inhibition of both NF-κB and YY1 and upregulation of DR5
|
Baritaki, S. |
|
2007 |
17 |
S |
p. 16- 1 p. |
artikel |
34 |
B4. Nitric oxide suppresses the expression of the tolerogenic transcription factor FOXP3 in tumor cells
|
Olson, S.Y. |
|
2007 |
17 |
S |
p. 17- 1 p. |
artikel |
35 |
B8. NO-aspirin 2 modulates carcinogen activation and detoxification enzyme expression in human HepG2 and LS180 cells
|
MacDonald, C.J. |
|
2007 |
17 |
S |
p. 18- 1 p. |
artikel |
36 |
B7. The NO donor glyceryl trinitrate induces FAS and dynamin 2 S-nitrosylation and perturbs their interaction in cancer cells
|
Leon, L. |
|
2007 |
17 |
S |
p. 17- 1 p. |
artikel |
37 |
B9. Tumoricidal activity of GIT-27NO depends on RNS and ROS generation
|
Mijatovic, S. |
|
2007 |
17 |
S |
p. 18- 1 p. |
artikel |
38 |
B10. Upregulation of the p53 homolog p73 and induction of the p53R2 ribonucleotide reductase subunit by nitric oxide
|
Tebbi, A. |
|
2007 |
17 |
S |
p. 18- 1 p. |
artikel |
39 |
C23. Age particularity of mitochondrial respiration and lipid peroxidation processes in rats under NO-system activation
|
Murashchuk, K. |
|
2007 |
17 |
S |
p. 25- 1 p. |
artikel |
40 |
C8. Artemisinin derivatives induce generation of nitric oxide and reactive oxygen species in cell lines of hematopoietic origin
|
Konkimalla, V.B. |
|
2007 |
17 |
S |
p. 21-22 2 p. |
artikel |
41 |
C13. Assessing morphological effects of nitric oxide donor compounds on cultured tumoral cells
|
Griveau, S. |
|
2007 |
17 |
S |
p. 23- 1 p. |
artikel |
42 |
C36. Can nitric oxide be used as a predictor of radiation response?
|
Vesper, B. |
|
2007 |
17 |
S |
p. 29- 1 p. |
artikel |
43 |
C28. Comparing the ability of normal and tumor cells to adapt to high levels of nitric oxide
|
Radosevich, J. |
|
2007 |
17 |
S |
p. 27- 1 p. |
artikel |
44 |
C6. Effect of different concentrations of L-arginine on proliferation of human cervical carcinoma cell line (Hela)
|
Jin, D. Dong |
|
2007 |
17 |
S |
p. 21- 1 p. |
artikel |
45 |
C33. Effect of nitric oxide on tumor necrosis factor-related apoptosis-inducing ligand expression during macrophage activation
|
Song, E.K. |
|
2007 |
17 |
S |
p. 28- 1 p. |
artikel |
46 |
C4. Expression of immune regulatory genes and involvement of nitric oxide after BCG treatment of urinary bladder cancer
|
Thiel, T. |
|
2007 |
17 |
S |
p. 20-21 2 p. |
artikel |
47 |
C21. GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG
|
Malaponte, G. |
|
2007 |
17 |
S |
p. 25- 1 p. |
artikel |
48 |
C10. Heparan sulfate, NO and cancer
|
Fransson, L.A. |
|
2007 |
17 |
S |
p. 22- 1 p. |
artikel |
49 |
C11. Hypoxia increases the shedding of MHC class I chain-related molecule (MIC) from the surface of tumour cells: Involvement of nitric oxide signalling
|
Graham, Charles H. |
|
2007 |
17 |
S |
p. 22- 1 p. |
artikel |
50 |
C19. Inflammation and cancer: Is NO the common link?
|
Kremer, D. |
|
2007 |
17 |
S |
p. 24- 1 p. |
artikel |
51 |
C30. Inflammatory nitrite at low pH in active colitis: A promotor of malignancy?
|
Roediger, W. |
|
2007 |
17 |
S |
p. 27- 1 p. |
artikel |
52 |
C9. Influence of nitric oxide and tissue oxygenation on invasive capacity of urinary bladder cancer
|
Ewe, C. |
|
2007 |
17 |
S |
p. 22- 1 p. |
artikel |
53 |
C2. iNOS down-regulation induced by flavopiridol, hyperforin and polyphenols in CLL cells is a caspase-dependent mechanism
|
Billard, C. |
|
2007 |
17 |
S |
p. 20- 1 p. |
artikel |
54 |
C29. iNOS expression in bladder cancer cells after BCG treatment
|
Kostkela, L. Renström |
|
2007 |
17 |
S |
p. 27- 1 p. |
artikel |
55 |
C25. Lithium for treatment and chemo-sensitization: Testing the hypothesis on SH-SY5Y cells in monolayer and 3D-spheroids
|
Oktem, G. |
|
2007 |
17 |
S |
p. 26- 1 p. |
artikel |
56 |
C3. Mechanisms of human colon cancer cells sensitization to nitric oxide-induced apoptosis
|
Cortier, M. |
|
2007 |
17 |
S |
p. 20- 1 p. |
artikel |
57 |
C7. Modulation of NO biosynthesis in A-375 melanoma cells by plasma membrane cholesterol
|
Durocher, S. |
|
2007 |
17 |
S |
p. 21- 1 p. |
artikel |
58 |
C1. Nitric oxide donors for treating IBD and related diseases
|
Assaf, P. |
|
2007 |
17 |
S |
p. 20- 1 p. |
artikel |
59 |
C35. Nitric oxide mimics rituximab (chimeric anti-CD20 mAb)-induced chemo/immuno-sensitization of resistant B-non Hodgkin’s lymphoma
|
Vega, M.I. |
|
2007 |
17 |
S |
p. 28- 1 p. |
artikel |
60 |
C24. Nitroglycerin treatment may increase response to docetaxel and carboplatin regimen via inhibitions of hypoxia-inducible factor-1 pathway in patients with lung adenocarcinoma
|
Nakayama, K. |
|
2007 |
17 |
S |
p. 25-26 2 p. |
artikel |
61 |
C14. NO-mediated chemosensitization of metastatic colon cancer in vivo: induction by NO of RKIP and AIF expression
|
Huerta, S. |
|
2007 |
17 |
S |
p. 23- 1 p. |
artikel |
62 |
C20. Novel NO-donation compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo
|
Maksimovic-Ivanic, D. |
|
2007 |
17 |
S |
p. 24-25 2 p. |
artikel |
63 |
Cover 2-Ed. Board
|
|
|
2007 |
17 |
S |
p. IFC- 1 p. |
artikel |
64 |
C34. Oxygen regulation of tumor perfusion unravels the central pressor activity of cell-free human S-nitrosohemoglobin
|
Sonveaux, P. |
|
2007 |
17 |
S |
p. 28- 1 p. |
artikel |
65 |
C12. Performances and applicability of electrochemical NO-sensor for in vivo detection of nitric oxide in tumor-bearing mice
|
Griveau, S. |
|
2007 |
17 |
S |
p. 22-23 2 p. |
artikel |
66 |
C38. Plasma levels of oxidative stress markers in patients with B–chronic lymphocytic leukemia
|
Zelen, I. |
|
2007 |
17 |
S |
p. 29- 1 p. |
artikel |
67 |
C31. Preventive effect of selenium on cytotoxicity in oxidant treated J774.1 macrophages cell line
|
Safir, N. |
|
2007 |
17 |
S |
p. 27- 1 p. |
artikel |
68 |
C5. Production of NO, superoxide anion, H2O2 and MDA in vitro by B lymphocytes of B-chronic lymphocytic leukemia patients
|
Djurdjevic, P. |
|
2007 |
17 |
S |
p. 21- 1 p. |
artikel |
69 |
C26. Real-time generation and detection of NO from nitrite in tumor cell lines
|
Panesar, N. |
|
2007 |
17 |
S |
p. 26- 1 p. |
artikel |
70 |
C17. Research of regulation of GTN on the Hela cells with microarray technique and two-dimensional electrophoresis
|
Jiang, H. |
|
2007 |
17 |
S |
p. 24- 1 p. |
artikel |
71 |
C18. Role of nitric oxide in deregulation of oral epithelial cell proliferation after ionizing radiation
|
Kang, M. |
|
2007 |
17 |
S |
p. 24- 1 p. |
artikel |
72 |
C32. Signaling of lipid A (OM-174) and IFN-γ synergy on tumor cell death
|
Sassi, N. |
|
2007 |
17 |
S |
p. 28- 1 p. |
artikel |
73 |
C37. Supressed effect of glyceryl trinitrate on tumor
|
Yaping, T. |
|
2007 |
17 |
S |
p. 29- 1 p. |
artikel |
74 |
C22. The effect of cytokine-induced macrophages on the tumour response to AQ4N and radiation
|
Mehibel, M. |
|
2007 |
17 |
S |
p. 25- 1 p. |
artikel |
75 |
C16. The effect of GTN on MMP-9/TIMP-1 expression and tumor metastasis of mice with lewis lung carcinoma
|
Jiang, H. |
|
2007 |
17 |
S |
p. 24- 1 p. |
artikel |
76 |
C27. The nitric oxide pathway in cns hemangioblastomas
|
Pluta, R. |
|
2007 |
17 |
S |
p. 26- 1 p. |
artikel |
77 |
C15. Therapeutic preclinical application of NO donor (e.g. DETANONOate) and CDDP in prostate tumor xenograft regression: molecular mechanism of synergy achieved in apoptosis
|
Huerta-Yepez, S. |
|
2007 |
17 |
S |
p. 23- 1 p. |
artikel |
78 |
First international conference nitric oxide and cancer
|
|
|
2007 |
17 |
S |
p. S1-S8 8 p. |
artikel |